Fibroblast Growth Factor (FGF) and FGF Receptor Families in Bone

Principles of Bone Biology: Volume 1-2, Third Edition

Volumn , Issue , 2008, Pages 1103-1132

  Hurley, Marja M ^a   Naski, Michael ^b   Marie, Pierre J ^c  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882478679     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373884-4.00065-3     Document Type: Chapter

References (466)

1. J.A. Abraham, A. Mergia, J.L. Whang, A. Tumolo, J. Friedman, K.A. Hjerrield, D. Gospodarowicz and J.C. Fiddes (1986) Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233 545-548.
2. J.A. Abraham, J.L. Whang, A. Tumolo, A. Mergia, J. Friedman, D. Gospodarowicz and J.C. Fiddes (1986) Human basic fibroblast growth factonnucleotide sequence and genomic organization. EMBO J. 5 2523-2528.
3. D. Agas, L. Marchetti, G. Menghi, S. Materazzi, G. Materazzi, M. Capacchietti, M.M. Hurley and M.G. Sabbieti (2007) Anti-apoptotic Bcl-2 enhancing requires FGF-2/FGF receptor 1 binding in mouse osteoblasts. J. Cell. Physiol. 214 145-152.
4. T. Aikawa, G.V. Segre and K. Lee (2001) Fibroblast Growth Factor Inhibits Chondrocytic Growth through Induction of p21 and Subsequent Inactivation of Cyclin E-Cdk2. J. Biol. Chem. 276 29347-29352.
5. J. Anderson, H.D. Burns, P. Enriquez-Harris, A.O.M. Wilkie and J.K. Heath (1998) Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum. Mol. Gen. 7 1475-1483.
6. J.L. Andreshak, et al. (1997) Tibial segmental defect repair: Chondrogenesis and biomedical strength modulated by basic fibroblast growth factor. Anat. Rec. 248 198-204.
7. E. Arman, Y. Haffner-Krausz Chen, J.K. Heath and P. Lonai (1998) Targeted disruption of fibroblast growthy factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc. Natl. Acad. Sci. USA. 95 5082-5087.
8. E. Arman, M. Haffner-Krausz Gorivodsky and P. Lonai (1999) FGFR2 is required for limb outgrowth and lung-branching morphogenesis. Proc. Natl. Acad. Sci. USA. 96(21), 11895-11899.
9. H.A. Armelin (1973) Pituitary extracts and steroid hormones in the control of 3T3 cell growth. Proc. Natl. Acad. Sci. USA. 70 2702-2706.
10. E. Arnaud, C. Touriol, M.C. Gensac, S. Vagner, H. Prats and A. Prats (1999) A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor. Mol. Cell Biol. 19(1), 505-514.
11. D. Aviezer, E. Levy, M. Safran, C. Svahn, E. Buddecke, A. Schmidt, G. David, I. Vlodavsky and A. Yayon (1994) Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J. Biol. Chem. 269 114-121.
12. A. Avivi, Y. Zimmer, A. Yayon, Y. Yarden and D. Givol (1991) Flg-2, a new member of the family of fibroblast growth factor receptors. Oncogene 6 1089-1092.
13. A. Baird and M. Klagsbrun (1991) The fibroblast growth factor family. Cancer Cells 3 239-243.
14. A. Baird, N. Ueno, F. Esch and N. Ling (1987) Distribution of fibroblast growth factors (FGFs) in tissues and structure-function studies with synthetic fragments of basic FGF. J. Cell Physiol. 5 101-106.
15. S. Banai, D. Shweiki, A. Pinson, M. Chandra, G. Lazarovici and E. Keshet (1994) Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis. Cardiovasc. Res. 28 1176-1179.
16. T. Baroni, P. Carinci, C. Lilli, C. Bellucci, M.C. Aisa, L. Scapoli, S. Volinia, F. Carinci, F. Pezzetti, M. Calvitti, A. Farina, C. Conte and M. Bodo (2005) P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation. J. Cell Physiol. 202(2), 524-535.
17. C.F. Bartels, H. Bukulmez, P. Padayatti, D.K. Rhee, C. van Ravenswaaij-Arts, R.M. Pauli, S. Mundlos, D. Chitayat, L.Y. Shih, L.I. Al-Gazali, S. Kant, T. Cole, J. Morton, V. Cormier-Daire, L. Faivre, M. Lees, J. Kirk, G.R. Mortier, J. Leroy, B. Zabel, C.A. Kim, Y. Crow, N.E. Braverman, F. van den Akker and M.L. Warman (2004) Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am. J. Hum. Genet. 75 27-34.
18. P. Bashkin, G. Neufeld, H. Gitay-Goren and I. Vlodavsky (1992) Release of cell surface-associated basic fibroblast growth factor by glycosylphosphatidylinositol-specific phospholipase C. J. Cell Physiol. 151 126-137.
19. J.N. Beresford, N.S. Fedarko, L.W. Fisher, R.J. Midura, M. Yanagishita, J.D. Termine and P.G. Robey (1987) Analysis of the proteoglycans synthesized by human bone cells in vitro. J. Biol. Chem. 262(35), 17164-17172.
20. M. Bernfield, M.T. Hinkes and R. Gallo (1993) Developmental expression of the syndecans: Possible function and regulation. Development 119 205-212.
21. S. Berrada, F. Lefebvre and M.F. Harmand (1995) The effect of recombinant human basic fibroblast growth factor rhFGF-2 on human osteoblast in growth and phenotype expression. In Vitro Cell Dev. 31 698-702.
22. F. Blanquaert, A.M. Delany and E. Canalis (1999) Fibroblast growth factor-2 induces hepatocyte growth factor/scatter factor expression in osteoblasts. Endocrinology 140 1069-1074.
23. B.E. Bobick and W.M. Kulyk (2006) MEK-ERK signaling plays diverse roles in the regulation of facial chondrogenesis. Exp. Cell Res. 312 1079-1092.
24. B.E. Bobick, T.M. Thornhill and W.M. Kulyk (2007) Fibroblast growth factors 2, 4, and 8 exert both negative and positive effects on limb, frontonasal, and mandibular chondrogenesis via MEK-ERK activation. J. Cell Physiol. 211 233-243.
25. P. Bohlen, A. Baird, F. Esch, N. Ling and D. Gospodarowicz (1984) Isolation and partial molecular characterization of pituitary fibroblast growth factor. Proc. Natl. Acad. Sci. USA. 81 5364-5368.
26. M.E. Bolander (1992) Regulation of fracture repair by growth factors. Proc. Soc. Exp. Biol. Med. 200(2), 165-170.
27. K.E. Bornfeldt, J.H. Arnquist and G. Norstedt (1990) Regulation of insulin-like growth factor-I gene expression by growth factors in cultured vascular smooth muscle cells. J. Endocrinol. 125 381-386.
28. J.M. Boudreaux and D.A. Towler (1996) Synergistic induction of osteocalcin gene expression: Identification of a bipartite element conferring fibroblast growth factor 2 and cyclic AMP responsiveness in the rat osteocalcin promoter. J. Biol. Chem. 271 7508-7515.
29. S. Bresnick and S. Schendel (1995) Crouzon disease correlates with low fibroblast growth factor receptor activity in stenosed cranial sutures. J. Craniofac. Surg. 6 245-250.
30. G. Brunner, H. Nguyen, J. Gabrilove, D.B. Rifkin and L. Wilson (1993) Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 3 631-638.
31. R.A. Buckland, J.M. Collinson, E. Graham, D.R. Davidson and R.E. Hill (1998) Antagonistic effects of FGF4 on BMP induction of apoptosis and chondrogenesis in the chick limb bud. Mech. Dev. 71 143-150.
32. W.H. Burgess and T. Maciag (1989) The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58 575-606.
33. L.W. Burrus and B.B. Olwin (1989) Isolation of a receptor for acidic and basic fibroblast growth factor from embryonic chick. J. Biol. Chem. 264 18647-18653.
34. L.W. Burrus, M.E. Zuber, B.A. Luebblecke, L. Olwin and B.B. Olwin (1993) Identification of a cysteine-rich receptor for fibroblast growth factors. Mol. Cell Biol. 12 5600-5609.
35. E. Canalis, M. Centrella and T. McCarthy (1988) Effects of basic fibroblast growth factor on bone formation in vitro. J. Clin. Invest. 81 1572-1577.
36. E. Canalis, J. Pash, B. Gabbitas, S. Rydziel and S. Varghese (1993) Growth factors regulate the synthesis of insulin-like growth-1 in bone cell cultures. Endocrinology 133 33-38.
37. G. Celli, W.J. LaRochelle, S. Mackem, R. Sharp and H. Merlino (1998) Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J. 17 1642-1655.
38. Z. Chang, K. Meyer, A.C. Rapraeger and A. Friedl (2000) Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ. FASEB J. 14(1), 137-144.
39. L.R. Chaudhary and L.V. Avioli (1997) Activation of extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2) by FGF-2 and PDGF-BB in normal human osteoblastic and bone marrow stromal cells: Differences in mobility and in-gel renaturation of ERK1 in human, rat, and mouse osteoblastic cells. Biochem. Biophys. Res. Commun. 238 134-139.
40. L.R. Chaudhary and L.V. Avioli (2000) Extracellular-signal regulated kinase signaling pathway mediates downregulation of type I procollagen gene expression by FGF-2, PDGF-BB, and okadaic acid in osteoblastic cells. J. Cell Biochem. 76 354-359.
41. A.T. Chellaiah, D.G. McEwen, S. Werner, J. Xu and D.M. Ornitz (1994) Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J. Biol. Chem. 269 11620-11627.
42. L. Chen and C.X. Deng (2005) Roles of FGF signaling in skeletal development and human genetic diseases. Front. Biosci. 10 1961-1976.
43. T.L. Chen, L.Y. Chang, D.A. DiGregorio, A.J. Perlman and Y.F. Huang (1993) Growth factor modulation of insulin-like growth factor-binding proteins in rat osteoblast-like cells. Endocrinology 133 1382-1389.
44. L. Chen, R. Adar, X. Yang, E.O. Monsonego, C. Li, P.V. Hauschka, A. Yayon and C.X. Deng (1999) Gly 369 Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J. Clin. Invest. 104 517-525.
45. L. Chen, D. Li, C. Li, A. Engel and C.X. Deng (2003) A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 33(2), 169-178. Erratum in Bone 37(6), 876 (2005)
46. D. Chikazu, Y. Hakeda, N. Ogata, K. Nemoto, A. Itabashi, T. Takato, M. Kumegawa, K. Nakamura and H. Kawaguchi (2000) Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase. J. Biol. Chem. 275 31444-31450.
47. J. Chimal-Monroy, J.A. Montero, Y. Ganan, D. Macias, J.A. Garcia-Porrero and J.M. Hurle (2002) Comparative analysis of the expression and regulation of Wnt5a, Fz4, and Frzb1 during digit formation and in micromass cultures. Dev. Dyn. 224 314-320.
48. A. Chines, R. Pacifici, L. Avioli, S.L. Teitelbaum and P.E. Korenblat (1991) Systemic mastocytosis presenting as osteoporosis: A clinical and histomorphometric study. J. Clin. Endocrinol. Metab. 72 140-144.
49. J.Y. Cho, C. Guo, M. Torello, G.P. Lunstrum, T. Iwata, C. Deng and W.A. Horton (2004) Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia. Proc. Natl. Acad. Sci. USA 101(2), 609-614.
50. K.Y. Choi, H.J. Kim, M.H. Lee, T.G. Kwon, H.D. Nah, T. Furuichi, T. Komor, S.H. Nam, Y.J. Kim, H.J. Kim and H.M. Ryoo (2005) Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development. Dev. Dyn. 233(1), 115-121.
51. M.A. Chotani, R.A. Payson, J.A. Winkles and I.M. Chiu (1995) Human fibroblast growth factor 1 gene expression in vascular smooth muscle cells is modulated via an alternate promoter in response to serum and phorbol ester. Nucleic Acids Res. 23 434-441.
52. H. Chusho, N. Tamura, Y. Ogawa, A. Yasoda, M. Suda, T. Miyazawa, K. Nakamura, K. Nakao, T. Kurihara, Y. Komatsu, H. Itoh, K. Tanaka, Y. Saito and M. Katsuki (2001) Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc. Natl. Acad. Sci. USA 98 4016-4021.
53. J.D. Coffin, R.Z. Florkiewicz, J. Neumann, T. Mort-Hopkins, G.W. Dorn III, P. Lightfoot, R. German, P.N. Howles, A. Kier, B.A. O'Toole, J. Sasse, A.M. Gonzalez, A. Baird and T.C. Doeschman (1995) Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol. Biol. Cell. 6 1861-1873.
54. M.J. Cohn, J.C. Izpisua-Belmonte, H. Abud, J.K. Heath and C. Tickle (1995) Fibroblast growth factors induce additional limb development from the flank of chick embryos. Cell 80 739-746.
55. J.S. Colvin, B.A. Bohne, D.G. Harding, D.G. McEwen and D.M. Ornitz (1996) Skeletal overgrowth and deafness in mice lacking firoblast growth factor receptor 3. Nat. Genet. 12 390-397.
56. C.M. Cowan, N. Quarto, S.M. Warren, A. Salim and M.T. Longaker (2003) Age related changes in the biomolecular mechanisms of calvarial osteoblast biology of fibroblast growth factor 2 signaling and osteogenesis. J. Biol. Chem. 278 32005-32013.
57. L. Creancier, D. Morello, P. Mercier and A.C. Prats (2000) Fibroblast growth factor 2 internal ribosome entry site (IRES) activity ex vivo and in transgenic mice reveals a stringent tissue-specific regulation. J. Cell Biol. 150 275-281.
58. P. Cuevas, J. Burgos and A. Baird (1988) Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. Biochem. Biophys. Res. Commun. 156 611-618.
59. F. Czubayko, R.V. Smith, H.C. Chung and A. Wellstein (1994) Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J. Biol. Chem. 269 28243-28248.
60. L. Dailey, D. Ambrosetti, A. Mansukhani and C. Basilico (2005) Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 16(2), 233-247.
61. G. David (1993) Integral membranes heparan sulfate proteoglycans. FASEB J. 7 1023-1030.
62. J.M. Davidson, M. Klagsbrun, K.E. Hill, A. Buckley, R. Sullivan, P.S. Brewer and S. Woodward (1985) Accelerated wound repair, cell proliferation, and collagen accumulation are produced by a cartilage-derived growth factor. J. Cell. Biol. 100 1219-1227.
63. C.N. Dealy, M.R. Sheghatoleslami, D. Ferrari and R.A. Kosher (1997) FGF-stimulated outgrowth and proliferation of limb mesoderm is dependent on syndecan-3. Dev. Biol. 184 343-350.
64. F. Debiais, A.M. Graulet and P.J. Marie (1998) Fibroblast growth factor-2 differently affects human neonatal calvaria osteoblastic cells depending on the stage of cell differentiation. J. Bone Miner. Res. 13 645-654.
65. F. Debiais, J. Lemonnier, E. Hay, P.H. Delannoy, J. Caverzasio and P.J. Marie (2001) Fibroblast growth factor-2 increases N-cadherin expression through protein kinase C and Src-kinase pathways in human calvaria osteoblasts. J. Cell. Biochem. 81(1), 68-81.
66. F. Debiais, G. Lefevre, J. Lemonnier, S. Le Mee, F. Lasmoles, F. Mascarelli and P.J. Marie (2004) Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, beta-catenin-independent signaling pathway. Exp. Cell. Res. 297(1), 235-246.
67. J.M. Delaisee, Y. Eeckhout and G. Vaes (1988) Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue. Endocrinology 123 264-276.
68. A.M. Delany and E. Canalis (1998) Basic fibroblast growth factor destabilizes osteonectin mRNA in osteoblasts. Am. J. Physiol. 43 C734-cC740.
69. A.M. Delany and E. Canalis (1998) Dual regulation of stromelysin-3 by fibroblast growth factor-2 in murine osteoblasts. J. Biol. Chem. 273 16595-16600.
70. A.L. Delezoide, C. Benoist-Lasselin, L. Legeai-Mallet, M. Le Merrer, A. Munnich, M. Vekemans and J. Bonaventure (1998) Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech. Dev. 77 19-30.
71. P. Delli Bovi, A.M. Curatola, F.G. Kern, A. Greco, M. Ittman and C. Basilico (1987) An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell. 50 729-737.
72. I. Delrieu (2000) The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): An insight into an intracrine mechanism. FEBS Lett. 468 6-10.
73. I. Delrieu, J. Faye, F. Bayard and A. Maret (1999) Inhibition of interleukin-6 promoter activity by the 24kDa isoform of fibroblast growth factor-2 in HeLa cells. Biochem. J. 340 201-206.
74. C.X. Deng, A. Wynshaw-Boris, M.M. Shen, C. Daugherty, D.M. Ornitz and P. Leder (1994) Murine FGFR-1 is required for early postim-plantation growth and axial organization. Genes Dev. 8 3045-3057.
75. C.A. Deng, F. Wynshaw-Boris, F. Zhou, A. Kuo and P. Leder (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84 911-921.
76. M.V. Dhodapkar, E. Abe, A. Theus, M. Lacy, J.K. Langford, B. Barlogie and R.D. Sanderson (1998) Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiation. Blood 91(8), 2679-2688.
77. C. Dickson and P. Acland (1990) Int-2: A member of the fibroblast growth factor family has different subcellular fates depending on the choice of initiation codon. Enzyme 44 225-234.
78. C. Dickson and G. Peters (1987) Potential oncogene product related to growth factors. Nature 326 833.
79. C. Dickson, P. Acland, R. Smith, M. Dixon, R. Deed, D. MacAllan, W. Walther, F. Fuller-Pace, P. Kiefer and G. Peters (1990) Characterization of int-2: A member of the fibroblast growth factor family. J. Cell Sci. 97(13), 87-96.
80. C. Dickson, R. Smith, S. Brookes and G. Peters (1990) Proviral insertions within the int-2 gene can generate multiple anomalous transcripts but leave the protein-coding domain intact. J. Virol. 64 784-793.
81. A. Dietz, V. Rudat, C. Conradt, H. Weidauer, A. Ho and T. Moehler (2000) Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapy. Head Neck 22 666-673.
82. C.A. Dionne, G. Crumley, F. Bellot, J.M. Kaplow, G. Searfoss, M. Ruta, W.H. Burgess, M. Jaye and J. Schlessinger (1990) Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 9 2685-2692.
83. R. Dono and R. Zeller (1994) Cell-type-specific nuclear translocation of fibroblast growth factor-2 isoforms during chicken kidney and limb morphogenesis. Dev. Biol. 163 316-330.
84. R. Dono, G. Texido, R. Dusel, H. Ehmke and R. Zeller (1998) Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J. 17 4213-4255.
85. C.R. Dunstan, R. Boyce, B.F. Boyce, I.R. Garrett, E. Izbicka, W.H. Burgess and G.R. Mundy (1999) Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats. J. Bone Miner. Res. 14 953-959.
86. F.P. Eckenstein, K. Kuzis, R. Nishi, W.R. Woodward, C. Meshul, L. Sherman and G. Ciment (1994) Cellular distribution, subcellular localization and possible functions of basic and acidic fibroblast growth factors. Biochem. Pharmacol. 47 103-110.
87. H. Emot, S. Tagashira, M.G. Mattei, M. Yamasaki, G. Hashimoto, T. Kat-sumata, M. Nakatsuka, D. Bimbaum, F. Coulier and N. Itoh (1997) Structure and expression of human fibroblast growth factor-10. J. Biol. Chem. 272 23191-23194.
88. M. Enomoto-Iwamoto, J. Kitagaki, E. Koyama, Y. Tamamura, C. Wu, N. Kanatani, T. Koike, H. Okada, T. Komori, T. Yoneda, V. Church, P.H. Francis-West, K. Kurisu, T. Nohno, M. Pacifici and M. Iwamoto (2002) The Wnt antagonist Frzb-1 regulates chondrocyte maturation and long bone development during limb skeletogenesis. Dev. Biol. 251 142-156.
89. G. Erdos, Y.J. Lee, J.M. Cho and P.M. Corry (1995) Heat-induced bFGF gene expression in the absence of heat shock element correlates with enhanced AP-1 binding activity. J. Cell Physiol. 164 404-413.
90. V.P. Eswarakumar, E. Monsonego-Ornan, M. Pines, I. Antonopoulou, G.M. Morriss-Kay and P. Lonai (2002) The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129(16), 3783-3793.
91. V.P. Eswarakumar and J. Schlessinger (2007) Skeletal overgrowth is mediated by deficiency in a specific isoform of fibroblast growth factor receptor 3. Proc. Natl. Acad. Sci. USA, 104(10), 3937-3942.
92. V.P. Eswarakumar, M.C. Horowitz, R. Locklin, G.M. Morriss-Kay and P. Lonai (2004) A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc. Natl. Acad. Sci. USA, 101(34), 12555-12560.
93. V.P. Eswarakumar, F. Ozcan, E.D. Lew, J.H. Bae, F. Tome, C.J. Booth, D.J. Adams, I. Lax and J. Schlessinger (2006) Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis. Proc. Natl. Acad. Sci. USA 103(49), 18603-18608.
94. A. Fakhry, C. Ratisoontorn, C. Vedhachalam, I. Salhab, E. Koyama, P. Leboy, M. Pacifici, R.E. Kirschner and H.D. Nah (2005) Effects of FGF-2/-9 in calvarial bone cell cultures: Differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone 36(2), 254-266.
95. P. Faloon, E. Arebtson, A. Kazarov, C.X. Deng, S.O. Porcher and K. Choi (2000) Basic fibroblast growth factor positively regulates hematopoietic development. Development 127 1931-1941.
96. N. Ferrara, K.A. Houck, L.B. Jakeman, J. Winer and D.W. Leung (1991) The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47 211-218.
97. M.S. Filla, P. Dam and A.C. Rapreager (1998) The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity. J. Cell. Physiol. 174(3), 310-321.
98. P.W. Finch, J.S. Rubin, T. Miki, D. Ron and S.A. Aaronson (1989) Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245 752-755.
99. R.Z. Florkiewicz and A. Sommer (1989) Human basic fibroblast growth factor gene encodes four polypeptides: Three initiate translation from non-AUG codons. Proc. Natl. Acad. Sci. USA. 86 3978-3981.
100. R.Z. Florkiewicz, A. Baird and A.M. Gonzalez (1991) Multiple forms of bFGF: Differential nuclear and cell surface localization. Growth Factors 4 265-275.
101. R.Z. Florkiewicz, R.A. Majack, R.D. Buechler and E. Florkiewicz (1995) Quantitative export of FGF-2 occurs through an alternative, energy-dependent, non-ER/Golgi pathway. J. Cell Physiol. 162 388-399.
102. J. Folkman and M. Klagsbrun (1987) Angiogenic factors. Science 235 442-447.
103. J. Folkman, M. Klagsbrun, J. Sasse, M.G. Wadzinski, D. Ingber and I. Vlodavsky (1988) A heparin-binding angiogenic protein—basic fibroblast growth factor—is stored within basement membrane. Am. J. Pathol. 130 393-400.
104. A. Fragale, M. Tartaglia, S. Bernardini, A.M. Michela-Di Stasi, C. Di Rocco, F. Velardi, A. Teti, P.A. Battaglia and S. Migliacco (1999) Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. Am. J. Pathol. 154 1465-1477.
105. R. Friesel and T. Maciag (1999) Fibroblast growth factor prototype release and fibroblast growth factor signaling. Thromb. Haemost. 82 748-754.
106. O. Fromigue, D. Modrowski and P.J. Marie (2005) Apoptosis in membranous bone formation: role of fibroblast growth factor and bone morphogenetic protein signaling. Crit. Rev. Eukaryot. Gene Expr. 15(1), 75-92.
107. S. Fukimoto and T. Yamashita (2007) FGF23 is a hormone-regulating phosphate metabolism-Unique biological characteristics of FGF23. Bone 40 1190-1195.
108. D.L. Fulgham, S.R. Widalm, S. Martin and J.D. Coffin (1999) FGF-2 dependent angiogenesis is a latent phenotype in basic fibroblast growth factor transgenic mice. Endothelium 6 185-195.
109. J.L. Gabrilove, K. White, Z. Rahman and E.L. Wilson (1994) Stem cell factor and basic fibroblast growth factors are synergistic in augmenting committed myeloid progenitor cell growth. Blood 83 907-910.
110. M.L. Gagnon, G.K. Moy and M. Klagsbrun (1999) Characterization of the promoter for the human antisense fibroblast growth factor-2 gene; regulation by Ets in Jurkat T cells. J. Cell Biochem. 72 492-506.
111. C. Galdemard, O. Brison and C. Lavialle (1995) The proto-oncogene FGF-3 is constitutively expressed in tumorigenic, but not in non-tumorigenic, clones of a human colon carcinoma cell line. Oncogene 10 2331-2342.
112. C. Galdemard, H. Yamagata, O. Brison and C. Lavialle (2000) Regulation of FGF-3 gene expression in tumorigenic and non-tumorigenic clones of a human colon carcinoma cell line. J. Biol. Chem. 275(23), 17364-17373.
113. C.M. Gelfman, C.M. Kelleher and L.M. Hjelmeland (1998) Differentiation of retinal pigment epithelial cells in vitro uncovers silencer activity in the FGF-5 gene promoter. Exp. Eye Res. 67 151-162.
114. S. Giordano, L. Sherman, W. Lyman and R. Morrison (1992) Multiple molecular weight forms of basic fibroblast growth factor are developmentally regulated in the central nervous system. Dev. Biol. 152 293-303.
115. N. Giuliani, G. Girasole, M. Pedrazzoni, G. Passeri, C. Gatti and M. Passeri (1995) Alendronate stimulates b-FGF production and mineralized nodule formation in human osteoblastic cells and osteoblastogenesis in human bone marrow cultures. J. Bone Miner. Res. 10(1), S171.
116. R.K. Globus, P. Patterson-Buckendahl and D. Gospodarowicz (1988) Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor. Endocrinology 123 98-105.
117. R.K. Globus, J. Plouet and D. Gospodarowicz (1989) Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matri. Endocrinology 124 1539-1547.
118. J.O. Gonatas, Z. Mourelatos, A. Stieber, W.S. Lane, J. Brosius and N.K. Gonatas (1995) MG-160, a membrane sialoglycoprotein of the medial cisternae of the rat Golgi apparatus, binds basic fibroblast growth factor and exhibits a high level of sequence identity to a chicken fibroblast growth factor receptor. J. Cell Sci. 108 457-467.
119. A.M. Gonzalez, D.J. Hill, A. Logan, P.A. Maher and A. Baird (1996) Distribution of fibroblast growth factor (FGF)-2 and FGF receptor-1 messenger RNA expression and protein presence in the mid-trimester human fetus. Pediat. Res. 39 375-385.
120. D. Gospodarowicz (1974) Localization of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 249 123-127.
121. D. Gospodarowicz (1975) Purification of a fibroblast growth factor from bovine pituitary. J. Biol. Chem. 250 2515-2520.
122. D. Gospodarowicz, H. Bialecki and T.K. Thakral (1979) The angiogenic activity of the fibroblast and epidermal growth factor. Exp. Eye Res. 28 501-514.
123. D. Gospodarowicz, J. Cheng, G.M. Lui, A. Baird and P. Böhlen (1984) Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: Identity with pituitary fibroblast growth factor. Proc. Natl. Acad. Sci. USA 81 6963-6967.
124. D. Gospodarowicz, N. Ferrara, L. Schweigerer and G. Neufeld (1987) Structural characterization and biological functions of fibroblast growth factor. Endocr. Rev. 8(2), 95-114.
125. S.E. Gould, W.B. Upholt and R.A. Kosher (1992) Syndecan-3: A member of the syndecan family of membrane-intercalated proteoglycans that is expressed in high amounts at the onset of chicken limb cartilage differentiation. Proc. Natl. Acad. Sci. USA 89 3271-3275.
126. V. Govindarajan and P.A. Overbeek (2006) FGF9 can induce endochondral ossification in cranial mesenchyme. BMC Dev. Biol. 6 1-14.
127. J.A. Greenwald, B.J. Mehrara, J.A. Spector, S.M. Warren, P.J. Fagenholz, L.E. Smith, P.J. Bouletreau, F.E. Crisera, H. Ueno and M.T. Longaker (2001) In vivo modulation of FGF biological activity alters cranial suture fate. Am. J. Pathol. 158(2), 441-452.
128. H. Guenou, K. Kaabeche, S.L. Mee and P.J. Marie (2005) A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome. Hum. Mol. Genet. 14(11), 1429-1439.
129. X. Guillonneau, F. Reghier-Ricard, O. Laplace, L. Jonet, M. Bryckaert, Y. Courtois and F. Mascarelli (1998) Fibroblast growth factor (FGF) soluble receptor 1 acts as a natural inhibitor of FGF2 neurotrophic activity during retinal degeneration. Mol. Biol. Cell. 9 2785-2802.
130. S. Guimond, M. Maccarana, B.B. Olwin, U. Lindahl and A.C. Rapraeger (1993) Activating and inhibitory heparin sequences for FGF-2 (basic FGF): Distinct requirements for FGF-1, FGF-2, and FGF-4. J. Biol. Chem. 268 23906-23914.
131. N. Hacohen, S. Kramer, D. Sutherland, Y. Hiromi and M.A. Krasnow (1998) Sprouty encode a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92 253-263.
132. M.K. Hajihosseini and J.K. Heath (2002) Expression patterns of fibroblast growth factors-18 and -20 in mouse embryos is suggestive of novel roles in calvarial and limb development. Mech Dev. 113(1), 79-83.
133. K. Hanada, J.E. Dennis and A.I. Caplan (1997) Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J. Bone Miner. Res. 12 606-1614.
134. T. Haque, S. Nakada and R.C. Hamdy (2007) A review of FGF18: Its expression, signaling pathways and possible functions during embryogenesis and post-natal development. Histol Histopathol. 22(1), 97-105.
135. V.K. Harris, C.M. Coticchia, B.L. Kagan, S. Ahmad, A. Wellstein and A.T. Riegel (2000) Induction of the angiogenic modulator fibroblast growth factor-binding protein by epidermal growth afctor is mediated through both MEK/ERK and p38 signal transduction pathways. J. Biol. Chem. 275 10802-10811.
136. K.C. Hart, S.C. Robertson and D.J. Donoghue (2001) Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation. Mol. Biol. Cell. 12(4), 931-942.
137. C. Hartmann and C.J. Tabin (2000) Dual roles of Wnt signaling during chondrogenesis in the chicken limb. Development 127 3141-3159.
138. C. Hartmann and C.J. Tabin (2001) Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell 104 341-351.
139. J. Hata, J. Takeo, C. Segawa and S. Yamashita (1997) A cDNA encoding fish fibroblast growth factor-2, which lacks alternative translation initiation. J. Biol. Chem. 272 7285-7289.
140. N.E. Hatch, M. Hudson, M.L. Seto, M.L. Cunningham and M. Bothwell (2006) Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F. J. Biol. Chem. 281(37), 27292-27305.
141. Y. Hattori, H. Odagiri, H. Nakatani, K. Miyagawa, K. Naito, H. Sakamoto, O. Katoh, T. Yoshida, T. Sugimura and M. Terada (1990) K-sam, an amplified gene in stomach cancer, is a member of the heparin-bind-ing growth factor receptor genes. Proc. Natl. Acad. Sci. USA. 87 5983-5987.
142. P.V. Hauschka, A.E. Mavrakos, M.D. Iafrati, S.E. Doleman and M. Klagsbrun (1986) Growth factors in bone matrix. J. Biol. Chem. 261 12665-12674.
143. J.W.B. Hershey, M.B. Mathews and N. Sonenberg (1996) Translational Control. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
144. P.A. Hill, A. Tumber and M.C. Meikle (1997) Multiple extracellular signals promote osteoblast survival and apoptosis. Endocrinology 138(9), 3849-3858.
145. J.M. Hock, M. Centrella and E. Canalis (1988) Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 122 254-260.
146. M. Hoshikawa, N. Ohbayashi, A. Yonamine, M. Konishi, K. Ozaki, S. Fukui and N. Itoh (1998) Structure and expression of a novel fibroblast growth factor, FGF-17, preferentially expressed in the embryonic brain. Biochem. Biophys. Res. Commun. 244 187-191.
147. K.A. Houck, D.W. Leung, A.M. Rowland, J. Winer and N. Ferrara (1992) Dual regulation of vascular endothelial growth factor bioavail-ability by genetic and proteolytic mechanisms. J. Biol. Chem. 267 26031-26037.
148. M.C. Hu, W.R. Qiu, Y.P. Wang, D. Hill, B.D. Ring, S. Scully, B. Bolon, M. DeRose, R. Luethy, W.S. Simonet, T. Arakawa and D.M. Danilenko (1998) FGF-18, a novel member of the fibroblast growth factor family. Stimulates hepatic and intestinal proliferation. Mol. Cell Biol. 18 6063-6074.
149. S.E. Hughes (1997) Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J. Histochem. Cytochem. 45 1005-1019.
150. M.M. Hurley, G. Gronowicz, B.E. Kream and L.G. Raisz (1990) Effect of heparin on bone formation in fetal rat calvaria. Calcif. Tissue Int. 46 183-188.
151. Hurley, M. M., Abreu, C., Kream, B. E., and Raisz, L. G. (1992a). Basic fibroblast growth inhibits IGF-I mRNA in the clonal osteoblastic cell line MC3T3-E1. In “Proceedings of the Eleventh International Congress on Calcium Regulating Hormones”. Elsevier, New York.
152. M.M. Hurley, M. Kessler, G. Gronowicz and L.G. Raisz (1992) The interaction of heparin and basic fibroblast growth factor on collagen synthesis in 21-day fetal rat calvariae. Endocrinology 130 675-681.
153. M.M. Hurley, C. Abreu, J.R. Harrison, A. Lichtler, L.G. Raisz and B.E. Kream (1993) Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268 5588-5593.
154. M.M. Hurley, C. Abreu, G. Gronowicz, H. Kawaguchi and J. Lorenzo (1994) Expression and regulation of basic fibroblast growth factor mRNA levels in mouse osteoblastic MC3T3-E1 cells. J. Biol. Chem. 269(12), 9392-9396.
155. M.M. Hurley, C. Abreu and Y. Hakeda (1995) Basic fibroblast growth factor regulates IGF-I binding proteins in the clonal osteoblastic cell line MC3T3-E1. J. Bone Miner. Res. 10 222-230.
156. M.M. Hurley, K. Marcello, C. Abren, C.E. Brinkerhoff, C.C. Bowik and M.S. Hibbs (1995) Transcriptional regulation of the collagenase gene by basic fibroblast growth factor in osteoblastic MC3T3-El cells. Biochem. Biophys. Res. Commun. 214 331-339.
157. M.M. Hurley, C. Abreu, K. Marcello, H. Kawaguchi, J. Lorenzo, J. Kalinowski, A. Ray and G. Gronowicz (1996) Regulation of NFIL-6 and IL-6 expression by basic fibroblast growth factor in osteoblasts. J. Bone Miner. Res. 11 760-767.
158. M.M. Hurley, K. Marcello, C. Abreu and M. Kessler (1996) Signal transduction by basic fibroblast growth factor in rat osteoblastic Pyla cells. J. Bone Miner. Res. 11 1256-1263.
159. M.M. Hurley, S.K. Lee, L.G. Raisz, P. Bemecker and J. Lorenzo (1998) Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures. Bone 22 309-316.
160. M.M. Hurley, S. Tetradis, Y. Huang, J. Hock, B.E. Kream, L.G. Raisz and M.G. Sabbieti (1999) Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells. J. Biol. Chem. 14 776-783.
161. M.M. Hurley, P. Marie and R. Florkiewicz (2002) Fibroblast growth factor and fibroblast growth factor receptor families. J.P. Bilezikian, L.G. Raisz, G. Rodan (Eds) Principles of bone biology Academic Press: San Diego 825-852.
162. M.M. Hurley, Y. Okada, L. Xiao, Y. Tanaka, M. Ito, N. Okimoto, T. Nakamura, C.J. Rosen, T. Doetschaman and J.D. Coffin (2006) Impaired bone anabolic response to parathyroid hormone in Fgf2−/− and Fgf2+/− mice. Biochem. Biophys. Res. Commun. 341 989-994.
163. N. Iberg, S. Rogelj, P. Fanning and M. Klagsbrun (1989) Purification of 18- and 22-kDa forms of basic fibroblast growth factor from rat cells transformed by the ras oncogene. J. Biol. Chem. 264 19951-19955.
164. O.A. Ibrahimi, A.V. Eliseenkova, A.N. Plotnikov, K. Yu, D.M. Ornitz and M. Mohammadi (2001) Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc. Natl. Acad. Sci. USA 98(13), 7182-7187.
165. O.A. Ibrahimi, F. Zhang, A.V. Eliseenkova, R.J. Linhardt and M. Mohammadi (2004) Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Hum. Mol. Genet. 13(1), 69-78.
166. K. Inui, H. Maeda, A. Sano, K. Fujioka, Y. Yutani, A. Sakawa, Y. Yamano, Y. Kato and T. Koike (1998) Local application of basic fibroblast growth factor minipellet induces the healing of segmental bony defects in rabbits. Biol. Trace Elem. Res. 63 490-495.
167. S. Iseki, A.O.M. Wilkie, J.K. Heath, T. Ishimura, K. Eto and G.M. Morriss-Kay (1997) FGFR-2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF-2. Development 124 3375-3384.
168. U.T. Iwaniec, K. Moore, M.F. Rivera, S.E. Myers, S.M. Vanegas and T.J. Wronski (2007) A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats. Osteoporos. Int. 18 351-362.
169. E.W. Jabs, X. Li, A.F. Scott, G. Meyers, W. Chen, M. Eccles, J. Mao, L.R. Charnas, C.E. Jackson and M. Jaye (1994) Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nature Genet. 8 275-279.
170. A. Jackson, S. Friedman, X. Zhan, K.A. Engleka, R. Forough and T. Maciag (1992) Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 89 10691-10695.
171. R.A. Jackson, S. Murali, A.J. van Wijnen, G.S. Stein, V. Nurcombe and S.M. Cool (2007) Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2. J. Cell. Physiol. 210(1), 38-50.
172. A.L. Jacob, C. Smith, J. Partanen and D.M. Ornitz (2006) Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev. Biol. 296(2), 315-318.
173. S. Jingushi, S. Heydeman, L. Kana, R. Macey and M.E. Bolandev (1990) Acidic fibrroblast growth factor (aFGF) injection stimulates cartilage enlargment and inhibits cartilage gene expression in rat fracture healing. J. Orthop. Res. 8 364-371.
174. R.L. Johnson and C.J. Tabin (1997) Molecular models for vetebrate limb development. Cell 90 979-990.
175. D. Johnson, S. Iseki, A.O. Wilkie and G.M. Morriss-Kay (2000) Expression patterns of Twist and Fgfr 1, -2 and -3 in the developing mouse coronal suture suggest a key role for twist in suture initiation and biogenesis. Mech. Dev. 91 341-345.
176. M.E. Joyce, S. Jingushi and S.P. Scully (1991) Role of growth factors in fracture healing. A. Barbule, M.D. Caldwell, W.H. Eaglstein (Eds) Clinical and Experimental Approaches to Dermal and Epidermal Repair: Normal and Chronic Wounds Wiley-Liss: New York 391-416.
177. K. Kaabeche, J. Lemonnier, S. Le Mee, J. Caverzasio and P.J. Marie (2004) Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation. J. Biol. Chem. 279(35), 36259-36267.
178. K. Kaabeche, H. Guenou, D. Bouvard, N. Didelot, A. Listrat and P.J. Marie (2005) Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation. J. Cell. Sci. 118 1223-1232.
179. A. Kaipainen, J. Korhonen, K. Pajusola, O. Aprelikova, M.G. Persico, B.I. Terman and K. Alitalo (1993) The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J. Exp. Med. 178 2077-2088.
180. R.M. Kapadia, A.R. Guntur, M.I. Reinhold and M.C. Naski (2005) Glycogen synthase kinase 3 controls endochondral bone development: Contribution of fibroblast growth factor 18. Dev. Biol. 285 496-507.
181. Y. Kato and M. Iwamoto (1990) Fibroblast growth factor is an inhibitor of chondrocytes terminal differentiation. J. Biol. Chem. 265 5903-5909.
182. H. Kato, R. Matsuo, O. Komiyama, T. Tanaka, M. Inazu, H. Kitagawa and T. Yoneda (1995) Decreased mitogenic and osteogenic responsiveness of calvarial osteoblasts isolated from aged rats to basic fibroblast growth factor. Gerontology 41 20-27.
183. T. Kato, H. Kawaguchi, K. Hanada, I. Aoyama, Y. Hiyama, T. Nakamura, K. Kuzutani, M. Tamura, T. Kurokawa and K. Nakamura (1998) Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbits. J. Orthop. Res. 16 654-659.
184. H. Kawaguchi, T. Kurokawa, K. Hanada, Y. Hiyama, M. Tamura, E. Ogata and T. Matsumoto (1994) Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135 774-781.
185. H. Kawaguchi, C. Pilbeam, G. Gronowicz, C. Abreu, B.S. Fletcher, H.R. Herschman, L. Raisz and M.M. Hurley (1995) Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. J. Clin. Invest. 96 923-930.
186. H. Kawaguchi, C.C. Pilbeam, J.R. Harrison and L.G. Raisz (1995) The role of prostaglandins in the regulation of bone metabolism. Clin. Orthop. 313 36-46.
187. H. Kawaguchi, D. Chikazu, K. Nakamura, M. Kumegawa and Y. Hakeda (2000) Direct and indirect actions of fibroblast growth factor 2 on osteo-clastic bone resorption in cultures. J. Bone Miner. Res. 15 466-473.
188. H. Kawaguchi, K. Nakamura, Y. Tabata, Y. Ikada, I. Aoyama, J. Anzai, T. Nakamura, Y. Hiyama and M. Tamura (2001) Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2. J. Clin.Endocrinol.Metab. 86(2), 875-880.
189. K. Keegan, D.E. Johnson, L.T. Williams and M.J. Hayman (1991) Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc. Natl. Acad. Sci. USA 88 1095-1099.
190. S.S. Kelpke, D. Reiff, C.W. Prince and J.A. Thompson (2001) Acidic fibroblast growth factor signaling inhibits peroxynitrite-induced death of osteoblasts and osteoblast precursors. J. Bone Miner. Res. 16(10), 1917-1925.
191. C. Kevil, P. Carter, B. Hu and A. DeBenedetti (1995) Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogene 11 2339-2348.
192. C.W. Kim, O.A. Goldberger, R.L. Gallo and M. Bernfield (1994) Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell, tissue-, and developing-specific patterns. Mol. Biol. Cell 7 797-805.
193. H.J. Kim, D.P.C. Rice, P.J. Kettunen and I. Thesleff (1998) FGF-, BMP- and Shh-mediated signaling pathways in the regulation of cranial suture morphogenesis and calvaria bone development. Development 125 1241-1251.
194. B.G. Kim, H.J. Kim, H.J. Park, Y.J. Kim, W.J. Yoon, S.J. Lee, H.M. Ryoo and J.Y. Cho (2006) Runx2 phosphorylation induced by fibroblast growth factor-2/protein kinase C pathways. Proteomics 6(4), 1166-1174.
195. D. Kimelman and M. Kirschner (1987) Synergistic induction of mesoderm by FGF and TGF-beta and the identification of an mRNA coding for FGF in the early Xenopus embryo. Cell 51 869-877.
196. D. Kimelman and M. Kirschner (1989) An antisense mRNA directs the covalent modification of the transcript encoding fibroblast growth factor in Xenopus oocytes. Cell 59 687-696.
197. D. Kimelman and A. Maas (1992) Induction of dorsal and ventral meso-derm by ectopically expressed Xenopus basic fibroblast growth factor. Development 114 261-269.
198. H. Kirikoshi, N. Sagara, T. Saitoh, K. Tanaka, H. Sekihara, K. Shiokawa and M. Katoh (2000) Molecular cloning and characterization of human FGF-20 on chromosome 8p21.3-p22. Biochem. Biopys. Res. Commun. 274 337-343.
199. M. Klagsbrun and A. Baird (1991) A dual receptor system is required for basic fibroblast growth factor activity. Cell 67 229-231.
200. M. Klagsbrun and S. Soker (1993) VEGF/VPF: The angiogenesis factor found? Curr. Biol. 3 699-702.
201. O. Klingenberg, A. Wiedlocha, A. Rapak, D. Khnykin, L. Citores and S. Olsnes (2000) Requirement for C-terminal end of fibroblast growth factor receptor 4 in translocation of acidic fibroblast growth factor to cytosol and nucleus. J. Cell Sci. 113 1827-1838.
202. T. Koda, S. Hasan, A. Sasaki, Y. Arimura and M. Kakinuma (1994) Regulatory sequences required for hst-l expression in embryonal carcinoma cells. FEBS. Lett. 342 71-75.
203. R. Kohl, M. Antoine, B. Olwin, C. Dickson and P. Kiefer (2000) Cysteine-rich fibroblast growth factor receptor alters secretion and intra-cellular routing of fibroblast growth factor 3. J. Biol. Chem. 275 15741-15748.
204. M. Koike, Y. Yamanaka, M. Inoue, H. Tanaka, R. Nishimura and Y. Seino (2003) Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK. J. Bone.Miner. Res. 18(11), 2043-2051.
205. H. Komaki, T. Tanaka, M. Chazono and T. Kikuchi (2006) Repair of segmental bone defects in rabbit tibiae using a complex of beta-tricalcium phosphate, type I collagen, and fibroblast growth factor-2. Biomaterials 27(29), 5118-5126.
206. S. Kornbluth, K.E. Paulson and H. Hanafusa (1988) Novel tyrosine kinase identified by phosphotyrosine antibody screening of cDNA libraries. Mol. Cell Biol. 8 5541-5544.
207. O. Kozawa, A. Suzuki and T. Uematsu (1997) Basic fibroblast growth factor induces interleukin-6 synthesis in osteoblasts autoregulation by protein kinase C. Cell Signal. 9 463-468.
208. O. Kozawa, H. Tokuda, H. Matsuno and T. Uematsu (1999) Involvement of p38 mitogen-activated protein kinase in basic fibroblast growth factor-induced interleukin-6 synthesis in osteoblasts. J. Cell Biochem. 74 479-485.
209. K. Krah, V. Mironov, W. Risau and I. Flamme (1994) Induction of vas-culogenesis in quail blastodisc-derived embryoid bodies. Dev. Biol. 164 123-132.
210. P. Krejci, B. Masri, V. Fontaine, P.B. Mekikian, M. Weis, H. Prats and W.R. Wilcox (2005) Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J. Cell Sci. 118 5089-5100.
211. P. Krejci, D. Krakow, P.B. Mekikian and W.R. Wilcox (2007) Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage. Pediatr. Res. 61(3), 267-272.
212. K. Kubota, S. Iseki, S. Kuroda, S. Oida, T. Iimura, W.R. Duarte, K. Ohya, I. Ishikawa and S. Kasugai (2002) Synergistic effect of fibroblast growth factor-4 in ectopic bone formation induced by bone morphogenetic protein-2. Bone 31(4), 465-471.
213. A. Kurtz, H. Wang, N. Darwiche, V. Harris and A. Wellstein (1997) Expression of a binding protein for FGF is associated with epithelial development and skin carcinogenesis. Oncogene 14 2671-2681.
214. E. Lajeunie, M. Catala and D. Renier (1999) Craniosynostosis: From a clinical description to an understanding of bone formation of the skull. Childs Nerv. Syst. 15(11–12), 676-680.
215. R. Lametsch, J.T. Rasmussen, L.B. Johnsen, S. Purup, K. Sejrsen, T.E. Petersen and C.W. Heegaard (2000) Structural characterization of the fibroblast growth factor-binding protein purified from bovine prepartum mammary gland secretion. J. Biol. Chem. 275 19469-19474.
216. E. Laplantine, F. Rossi, M. Sahni, C. Basilico and D. Cobrinik (2002) FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest. J. Cell. Biol. 158(4), 741-750.
217. J.E. Lazarus, A. Hegde, A.C. Andrade, O. Nilsson and J. Baron (2007) Fibroblast growth factor expression in the postnatal growth plate. Bone 40 577-586.
218. S.Y. Le and J.V. Maizel Jr. (1997) A common RNA structural motif involved in the internal initiation of translation of cellular mRNAs. Nucleic Acids Res. 25 362-369.
219. P.L. Lee, D.E. Johnson, L.S. Cousens, V.A. Fried and L.T. Williams (1989) Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science 245 57-60.
220. L. Legeai-Mallet, C. Benoist-Lasselin, A.L. Delezoide, A. Munnich and J. Bonaventure (1998) Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia. J. Biol. Chem. 273(21), 13007-13014. Erratum in: J. Biol. Chem. 273(30), 19358
221. J. Lemonnier, M. Hott, P. Delannoy, A. Lomri, D. Modrowski and P.J. Marie (2000) The S252W fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation. Exp. Cell. Res. 256 158-167.
222. J. Lemonnier, E. Hay, P. Delannoy, A. Lomri, D. Modrowski, J. Caverzasio and P.J. Marie (2001) Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis. J. Bone. Miner. Res. 16(5), 832-845.
223. J. Lemonnier, E. Hay, P. Delannoy, O. Fromigue, A. Lomri, D. Modrowski and P.J. Marie (2001) Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1. Am. J. Pathol. 158(5), 1833-1842.
224. C.F. Li and M. Hughes-Fulford (2006) Fibroblast growth factor-2 is an immediate-early gene induced by mechanical stress in osteogenic cells. J. Bone. Miner Res. 21(6), 946-955.
225. A.W. Li and P.R. Murphy (2000) Expression of alternatively sliced FGF-2 antisense RNA transcripts in the central nervous system: Regulation of FGF-2 mRNA translation. Mol. Cell. Endocrinol. 162(1-2), 69-78.
226. C. Li, L. Chen, T. Iwata, M. Kitagawa, X.Y. Fu and C.X. Deng (1999) A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum. Mol. Genet. 8 35-44.
227. H. Liang, S. Pun and T.J. Wronski (1999) Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats. Endocrinology 140 5780-5788.
228. J.C. Lievens, T. Rival, M. Iche, H. Chneiweiss and S. Birman (2005) Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila. Hum. Mol. Genet. 14(5), 713-724.
229. P.S. Lightfoot, R. Swisher, J.D. Coffin, TC. Doetschman and R.Z. German (1997) Ontogenetic limb bone scaling in basic fibroblast growth factor (FGF-2) transgenic mice. Growth. Dev. Aging, 61 127-139.
230. X. Lin, E.M. Buff, N. Perrimon and A.M. Michelson (1999) Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 126 3715-3723.
231. Z. Liu, J. Xu, J.S. Colvin and D.M. Ornitz (2002) Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev. 16(7), 859-869.
232. Z. Liu, K.J. Lavine, I.H. Hung and D.M. Ornitz (2007) FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. Dev. Biol. 302(1), 80-91.
233. R. Locklin, M.C. Williamson, J.N. Beresford, J.T. Triffitt and M.E. Owen (1995) In vitro effects of growth factors and dexamethasone on rat marrow stromal cells. Clin. Orthop. 313 27-35.
234. A. Logan, S.A. Frautschy, A.-M. Gonzalez and A. Baird (1992) A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high-affinity receptors (fig) following a localized cortical brain injury. J. Neurosci. 12 3828-3837.
235. A. Lomri, J. Lemonnier, M. Hott, N. de Perseval, E. Lajeunie, A. Munnich, D. Renier and P.J. Marie (1998) Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J. Clin. Invest. 101 1310-1317.
236. A. Lomri, J. Lemonnier, P. Delannoy and P.J. Marie (2001) Increased expression of protein kinase Calpha, interleukin-1alpha, and RhoA guanosine 5′-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: Identification by analysis of complementary DNA microarray. J. Bone Miner. Res. 16(4), 705-712.
237. Y. Luan, C.A. Praul, C.V. Gay and R.M. Leach Jr (1996) Basic fibroblast growth factor: An autocrine growth factor for epiphyseal growth plate chondrocytes. J. Cell Biochem. 62 372-382.
238. T.A. Luster, L.R. Johnson, T.K. Nowling, K.A. Lamb, S. Philipsen and A. Rizzino (2000) Effects of three Sp1 motifs on the transcription of the FGF-4 gene. Mol. Reprod. Dev. 57 4-15.
239. Y.-G. Ma, E. Rosfjord, C. Huebert, P. Wilder, J. Tiesman, D. Kelly and A. Rizzino (1992) Transcriptional regulation of the murine k-FGF gene in embryonic cell lines. Dev. Biol. 154 45-54.
240. F. Madiai, K.V. Hackshaw and I. Chiu (1999) Characterization of the entire transcription unit of the mouse fibroblast growth factor 1 (FGF-1) gene. J. Biol. Chem. 274 11937-11944.
241. M. Mali, K. Elenius, H.M. Miettinen and M. Jalkanen (1993) Inhibition of basic fibroblast growth factor-induced growth promotion by overexpression of syndecan-1. J. Biol. Chem. 268 24215-24222.
242. E.E. Mancilla, F. De Luca, J.A. Uyeda, F.S. Czerwiec and J. Baron (1998) Effects of fibroblast growth factor-2 on longitudinal bone growth. Endocrinology 139 2900-2904.
243. K. Mangasarian, Y. Li, A. Mansukhani and C. Basilico (1997) Mutation associated with Crouzon syndrome causes ligand-independent dimerization and activation of FGF receptor-2. J. Cell Physiol. 172 117-125.
244. A. Mansukhani, P. Bellosta, M. Sahni and C. Basilico (2000) Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J. Cell Biol. 149 1297-1308.
245. A. Mansukhani, D. Ambrosetti, G. Holmes, L. Cornivelli and C. Basilico (2005) Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. J. Cell Biol. 168(7), 1065-1076.
246. P.J. Marie (2003) Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 316 23-32.
247. P.J. Marie, F. Debiais and E. Hay (2002) Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling. Histol. Histopathol. 17(3), 877-885.
248. P.J. Marie, J.D. Coffin and M.M. Hurley (2005) FGF and FGFR signaling in chondrodysplasias and craniosynostosis. J. Cell. Biochem. 96(5), 888-896.
249. I. Marics, J. Adelaide, E. Raybaud, M.-G. Mattei, F. Courier, J. Planche, O. De Lapeyriere and D. Birnbaum (1989) Characterization of the HST-related FGF.6 gene, a new member of the fibroblast growth factor gene family. Oncogene. 4 335-340.
250. G.R. Martin (1998) The roles of FGFs in the early development of vertibrate limbs. Genes Dev. 12 1571-1586.
251. I. Martin, A. Muraglia, G. Campanile, R. Cancedda and R. Quarto (1997) Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138 4456-4462.
252. I.J. Mason (1994) The ins and outs of fibroblast growth factors. Cell 78 547-552.
253. I.M. Mathijssen, H. van Leeuwen, C. Vermeij-Keers and J.M. Vaandrager (2001) FGF-4 or FGF-2 administration induces apoptosis, collagen type I expression, and mineralization in the developing coronal suture. J. Craniofac. Surg. 12(4), 399-400.
254. H. Mayahara, T. Ito, H. Nagai, H. Miyajima, R. Tsukuda, S. Taketomi, J. Mizoguchi and K. Kato (1993) In vivo stimulation ofendosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 9 73-80.
255. T.L. McCarthy, M. Centrella and E. Canalis (1989) Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells. Endocrinology 125 2118-2126.
256. L.M. McDowell, B.A. Frazier, D.R. Studelska, K. Giljum, J. Chen, J. Liu, K. Yu, D.M. Ornitz and L. Zhang (2006) Inhibition or activation of Apert syndrome FGFR2 (S252W) signaling by specific glycosaminoglycans. J. Biol. Chem. 281(11), 6924-6930.
257. W.L. McKeehan, X. Wu and M. Kan (1999) Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex. J. Biol. Chem. 274 21511-21514.
258. J.R. McWhirter, M. Goulding, J.A. Weiner, J. Chun and C. Murre (1997) A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbxl. Development 124 3221. 3221
259. M.M. Megard, M. Cuche, A. Grapeloux, C. Bojoly and P.J. Meunier (1982) L'heparinotherapie. Nouv. Presse Med. 11 261-264.
260. B.J. Mehrara, R.J. Mackool, J.G. McCarthy, G.K. Gittes and M.T. Longaker (1998) Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor 2 in rat cranial sutures. Plast. Reconstr. Surg. 102 1805-1820.
261. V.B. Mehta, L. Connors, H.C. Wang and I.M. Chiu (1998) Fibroblast variants nonresponsive to fibroblast growth afctor 1 are defective in its nuclear translocation. Biol. Chem. 273 4197-4205.
262. V. Midy and J. Plouet (1994) Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem. Biophys. Res. Commun. 199 380-386.
263. P. Mignatti, T. Morimoto and D.B. Rifkin (1992) Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum–Golgi complex. J. Cell Physiol. 151 81-93.
264. D.L. Miller, O. Sagario, O. Bashayan, R. Basch and C. Basilico (2000) Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Mol. Cell. Biol. 26 2260-2268.
265. M. Mina and B. Havens (2007) FGF signaling in mandibular skeletogenesis. Orthodont. Craniofac. Res. 10 59-66.
266. E. Minina, C. Kreschel, M.C. Naski, D.M. Ornitz and A. Vortkamp (2002) Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev. Cell. 3(3), 439-449.
267. A. Miyake, M. Konishi, F.H. Martin, N.A. Hemday, K. Ozaki, S. Yamamoto, T. Mikami, T. Arakawa and Itoh (1998) Structure and expression of a novel member, FGF-16, on the fibroblast growth factor family. Biochem. Biophys. Res. Commun. 243 148-152.
268. M. Miyamoto, K.-I. Naruo, C. Seko, S. Matsumoto, T. Kondo and T. Kurokawa (1993) Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol. Cell Biol. 13 4251-4259.
269. M.Z. Moftah, S.A. Downie, N.B. Bronstein, N. Mezentseva, J. Pu, P.A. Maher and S.A. Newman (2002) Ectodermal FGFs induce perinodular inhibition of limb chondrogenesis in vitro and in vivo via FGF receptor 2. Dev. Biol. 249 270-282.
270. M. Mohammadi, J. Schlessinger and S.R. Hubbard (1996) Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86(4), 577-587.
271. A. Molténi, D. Modrowski, M. Hott and P.J. Marie (1999) Differential expression of fibroblast growth factor receptor-1, -2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular condyle and calvaria during osteogenic diffentiation in vitro. Bone 24 337-347.
272. A. Molténi, D. Modrowski, M. Hott and P.J. Marie (1999) Alterations of matrix- and cell-associated proteoglycans inhibit osteogenesis and growth response to FGF-2 in cultured rat mandibular condyle and calvaria. Cell Tissue Res. 295 523-536.
273. A. Montero, Y. Okada, M. Tomita, M. Ito, H. Tsurukami, T. Nakamura, T. Doetschman, J.D. Coffin and M.M. Hurley (2000) Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J. Clin. Invest. 105 1085-1093.
274. R. Montesano, J.D. Vasalli, A. Baird, R. Guillemin and L. Orci (1986) Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. USA 83 7297-7301.
275. R. Moore, P. Ferretti, A. Copp and P. Thorogood (2002) Blocking endogenous FGF-2 activity prevents cranial osteogenesis. Dev. Biol. 243(1), 99-114.
276. D. Most, J.P. Levine, J. Chang, J. Sung, J.G. McCarthy, S.A. Schendel and M.T. Longaker (1998) Studies in cranial suture biology: Up-regulation of transforming growth factor-fl1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat. Plast. Reconstr. Surg. 101 1431-1440.
277. M. Muenke, U. Schell, A. Hehr, N.H. Robin, H.W. Losken, A. Schinzel, L.J. Pulleyn, P. Rutland, W. Reardon, S. Malcolm and R.M. Winter (1994) A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat. Genet. 8 269-274.
278. A. Muesch, E. Hartmann, K. Rohde, A. Rubartelli, R. Sitia and T.A. Rapoport (1990) A novel pathway for secretory proteins? Trends Biol. Sci. 15 86-88.
279. G.R. Mundy and G.D. Roodman (1987) Osteoclast ontogeny and function. J. Bone Miner. Res. 5 209-279.
280. G. Mundy, R. Garrett, S. Harris, J. Chan, D. Chen, G. Rossini, B. Boyce, M. Zhao and G. Gutierrez (1999) Stimulation of bone formation in vitro and in rodents by statins. Science 286 1946-1949.
281. I. Munoz-Sanjuan, P.M. Smallwod and J. Nathans (2000) Isoform diversity among fibroblast growth factor homologous factors is generated by alternative promoter usage and differential splicing. J. Biol. Chem. 275 2589-2597.
282. A. Murakami, D. Grinberg, J. Thurlow and C. Dickson (1993) Identification of positive and negative regulatory elements involved in the retinoic acid/cAMP induction of Fgf-3 transcription in F9 cells. Nucleic Acids Res. 21 5351-5359.
283. A. Murakami, J. Thurlow and C. Dickson (1999) Retinoic acid-related expression of fibroblast growth factor 3 requires the interaction between a novel transcription factor and GATA-4. J. Biol. Chem. 274 17242-17248.
284. R.L. Myers, R.A. Payson, M.A. Chotani, L.L. Deaven and I.-M. Chiu (1993) Gene structure and differential expression of acidic fibroblast growth factor mRNA: Identification and distribution of four different transcripts. Oncogene 8 341-349.
285. R.L. Myers, S.K. Ray, R. Eldridge, M.A. Chotani and I.M. Chiu (1995) Functional characterization of the brain-specific FGF-1 promoter, FGF-1. B. J. Biol. Chem. 270 8257-8266.
286. H. Nagai, R. Tsukuda and H. Mayahara (1995) Effects of basic fibroblast growth factor (bFGF) on bone formation in growing rats. Bone 16 367-373.
287. H. Nagai, R. Tsukuda, H. Yamasaki and H. Mayahara (1999) Systemic injection of FGF-2 stimulates endocortical bone modelling in SAMP6, a murine model of low turnover osteopenia. J. Vet. Med. Sci. 61 869-875.
288. N. Nakagawa, H. Yasuda, K. Yano, S. Mochizuki, N. Kobayashi, H. Fujimoto, N. Shima, T. Morinaga, D. Chikazu, H. Kawaguchi and K. Higashio (1999) Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells. Biochem. Biophys. Res. Commun. 265(1), 158-163.
289. T. Naganawa, L. Xiao, E. Abogunde, T. Sobue, I. Kalajzic, M. Sabbieti, D. Agas and M.M. Hurley (2006) In vivo and in vitro comparison of the effects of FGF-2 null and haplo-insufficiency on bone formation in mice. Biochem Biophys. Res. Commun. 339 490-498.
290. T. Nakamura, K. Hanada, M. Tamura, T. Shibanushi, H. Nigi, M. Tagawa, S. Fukumoto and T. Matsumoto (1995) Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 136 1276-1284.
291. K. Nakamura, H. Kawaguchi, I. Aoyama, K. Hanada, Y. Hiyama, T. Awa, M. Tamura and T. Kurokawa (1997) Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits. J. Orthop. Res. 15 307-313.
292. Y. Nakamura, K. Tensho, H. Nakaya, M. Nawata, T. Okabe and S. Wakitani (2005) Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone 36(3), 399-407. Erratum in: Bone. 2006;39(1, 222. Bone. 2007;40(1), 244–245
293. M.C. Naski and D.M. Ornitz (1998) FGF signaling in skeletal development. Front. Biosci. 3 D781-dD794.
294. M.C. Naski, Q. Wang, J. Xu and D.M. Ornitz (1996) Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet. 13 233-237.
295. M.C. Naski, J.S. Colvin, J.D. Coffin and D.M. Ornitz (1998) Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 125 4977-4988.
296. K.M. Neilson and R.E. Friesel (1995) Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J. Biol. Chem. 270 26037-26040.
297. K.M. Neilson and R. Friesel (1996) Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains. J. Biol. Chem. 271 25049-25057.
298. E.P. Newberry, J.M. Boudreaux and D.A. Towler (1996) The rat osteocalcin fibroblast growth factor (FGF-)-responsive element: An okadaic acid-sensitive, FGF-selective transcriptional response motif. Mol. Endocrinol. 10 1029-1040.
299. E.P. Newberry, D. Willis, T. Latifi, J.M. Boudreaux and D.A. Towler (1997) Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element. Mol. Endocrinol. 11 1129-1144.
300. M. Nguyen, H. Watanabe, A.E. Budson, J.P. Richie, D.F. Hayes and J. Folkman (1994) Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. JNCI 86 356-361.
301. T. Nishimura, Y. Utsunomiya, M. Hoshikawa, H. Ohuchi and N. Itoh (1999) Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain. Biochim. Biophys. Acta 1444 148-151.
302. T. Nishimura, Y. Nakatake, M. Konishi and N. Itoh (2000) Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim. Biophys. Acta 1492 203-206.
303. L. Niswander (1996) Growth factor interactions in limb development. Ann. N. Y. Acad. Sci. 785 23-26.
304. L. Niswander, C. Tickle, A. Vogel and G. Martin (1994) Function of FGF-4 in limb development. Mol. Reprod. Dev. 39 83-89.
305. M. Noda and R. Vogel (1989) Fibroblast growth factor enhances type β1 transforming growth factor gene expression in osteoblast-like cells. J. Cell Biol. 109 2529-2535.
306. D. Noff, S. Pitaru and N. Savion (1989) Basic fibroblast growth factor enhances the capacity of bone marrow cells to form bone-like nodules in vitro. FEBS. Lett. 250 619-621.
307. N. Ohbayashi, M. Hoshikawa, S. Kimura, M. Yamasaki, S. Fukui and N. Itoh (1998) Structure and expression of the mRNA encodinga novel fibroblast growth factor, FGF-18. J. Biol. Chem. 273(29), 18161-18164.
308. N. Ohbayashi, M. Shibayama, Y. Kurotaki, M. Imanishi and T.N.S. Fujimori (2002) FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 16(7), 870-879.
309. Y. Okada, A. Montero, X. Zhang, T. Sobue, J. Lorenzo, T. Doetschman, J.D. Coffin and M.M. Hurley (2003) Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone. J. Biol. Chem. 278 21258-21266.
310. M. Okada-Ban, J.P. Thiery and J. Jouanneau (2000) Fibroblast growth factor-2. Int. J. Cell Biol. 23 263-267.
311. L.J. Oliver, D.B. Rifkin, J. Gabrilove, M.-J. Hannocks and E.L. Wilson (1990) Long term human bone marrow stromal cells in the presence of basic fibroblast growth factor. Growth Factors 3 231.
312. B.B. Olwin, K. Arthur, K. Hannon, P. Hein, A. McFall, B. Riley, G. Szebenyi, Z. Zhou, M.E. Zuber, A.C. Rapraeger, J.F. Fallon and A.J. Kudla (1994) Role of FGFs in skeletal muscle and limb development. Mol. Reprod. Dev. 39 90-101.
313. D.M. Ornitz (2000) FGFs, heparan sulfate and FGFRs: Complex interactions essential for development. Bioessays 22 108-112.
314. D.M. Ornitz (2000) Fibroblast growth factors, chondrogenesis and related clinical disorders. E. Canalis (Eds) Skeletal Growth Factors Baltimore: Lippincott Williams & Wilkins 197-209.
315. D.M. Ornitz (2005) FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev. 16(2), 205-213.
316. D.M. Ornitz and P. Leder (1992) Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J. Biol. Chem. 267 16305-16311.
317. D. Ornitz and P.J. Marie (2002) FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16(12), 1446-1465.
318. D.M. Ornitz, J. Xu, J.S. Colvin, D.G. McEwen, C.A. MacArthur, F. Coulier, G. Gao and M. Goldfarb (1996) Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271 15292-15297.
319. A. Orr-Urtreger, D. Givol, A. Yayon, Y. Yarden and P. Lonai (1991) Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development 113 1419-1434.
320. A. Orr-Urtreger, M.T. Bedford, T. Burakova, E. Arman, Y. Zimmer, A. Yayon, D. Givol and P. Lonai (1993) Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR-2). Dev. Biol. 158 475-486.
321. S. Ortega, M. Ittmann, S.H. Tsang, M. Ehrlich and C. Basilico (1998) Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl. Acad. Sci. USA. 95 5672-5677.
322. A. Ozasa, Y. Komatsu, A. Yasoda, M. Miura, Y. Sakuma, Y. Nakatsuru, H. Arai, N. Itoh and K. Nakao (2005) Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells. Bone 36 1056-1064.
323. W.J. Park, G.A. Bellus and E.W. Jabs (1995) Mutations in fibroblast growth factor receptors: Phenotypic consequences during eukaryotic development. Am. J. Hum. Genet. 57 748-754.
324. W.J. Park, C. Theda, N.E. Maestri, G.A. Meyers, J.S. Fryburg, C. Dufresne and M.M. Cohen (1995) Analysis of phenotypic features and FGFR-2 mutations in Apert syndrome. Am. J. Hum. Genet. 57 321-328.
325. J. Partanen, T.P. Makela, E. Eerola, J. Korhonen, H. Hirvonen, L. Claesson-Welsh and K. Alitalo (1991) FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J. 10 1347-1354.
326. E.B. Pasquale (1990) A distinctive family of embryonic protein-tyrosine kinase receptors. Proc. Natl. Acad. Sci. USA 87 5812-5816.
327. V. Patry, B. Bugler, F. Amalric, J.-C. Promé and H. Prats (1994) Purification and characterization of the 210-amino acid recombinant basic fibroblast growth factor form (FGF-2). FEBS. Lett. 349 23-28.
328. G. Patstone, E.B. Pasquale and P.A. Maher (1993) Different members of the fibroblast growth factor receptor family are specific to distinct cell types in the developing chicken embryo. Dev. Biol. 155 107-123.
329. K.G. Peters, S. Werner, G. Chen and L.T. William (1992) Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114 233-243.
330. K. Peters, D. Ornitz, S. Werner and L. Williams (1993) Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol. 155 423-430.
331. R.S. Piotrowicz, P.A. Maher and E.G. Levin (1999) Dual activities of the 22–24kDa basic fibroblast growth factor: Inhibition of migration and stimulation of prolifeation. J. Cell Physiol. 178 144-153.
332. S. Pitaru, S. Kotev-Emeth, D. Noff, S. Kaffuler and N. Savion (1993) Effect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells: Enhanced development of mineralized bone-like tissue in culture. J. Bone Miner. Res. 8(8), 919-926.
333. A.N. Plotnikov, S.R. Hubbard, J. Schlessinger and M. Mohammadi (2000) Crystal structures of two FGF–FGFR complexes reveal the determinants of ligand–receptor specificity. Cell 101 413-434.
334. P.P. Powell and M. Klagsbrun (1991) Three forms of rat basic fibroblast growth factor are made from a single mRNA and localize to the nucleus. J. Cell Physiol. 148 202-210.
335. R.A. Power, U.T. Iwaniec, K.A. Magee, N.G. Mitova-Caneva and T.J. Wronski (2004) Basic fibroblast growth factor has rapid bone anabolic effects in ovariectomized rats. Osteoporos. Int. 15 716-723.
336. H. Prats, M. Kaghad, A.C. Prats, M. Klagsbrun, J.M. Lelias, P. Liauzun, P. Chalon, J.P. Tauber, F. Amalric, J.A. Smith and D. Caput (1989) High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc. Natl. Acad. Sci. USA 86 1836-1840.
337. C.A. Praul, B.C. Ford and R.M. Leach (2002) Effect of fibroblast growth factors 1, 2, 4, 5, 6, 7, 8, 9 and 10 on avian chondrocyte proliferation. J. Cell. Biochem. 84 359-366.
338. M. Presta, D. Moscatelli, J. Joseph-Silverstein and D.B. Rifkin (1986) Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol. Cell Biol. 6 4060-4066.
339. S. Pri-Chen, S. Pitaru, F. Lokiec and N. Savion (1998) Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture. Bone 23 111-117.
340. R. Priore, L. Dailey and C. Basilico (2006) Downregulation of Akt activity contributes to the growth arrest induced by FGF in chondrocytes. J. Cell Physiol. 207 800-808.
341. N. Quarto, D. Talarico, R. Florkiewicz and D.B. Rifkin (1991) Selective expression of high molecular weight basic fibroblast growth factor confers a unique phenotype to NIH 3T3 cells. Cell Regul. 2 699-708.
342. M.L. Radomsky, A.Y. Thompson, R.C. Spiro and J.W. Poser (1998) Potential role of fibroblast growth factor in enhancement of fracture healing. Clin. Orthop. 355(Suppl), 283-293.
343. A.C. Rapraeger (1993) The coordinated regulation of heparan sulfate, syndecans and cell behavior. Curr. Opin. Cell Biol. 5 844-853.
344. C. Ratisoontorn, G.F. Fan, K. McEntee and H.D. Nah (2003) Activating (P253R, C278F) and dominant negative mutations of FGFR2: Differential effects on calvarial bone cell proliferation, differentiation, and mineralization. Connect. Tissue Res. 44(Suppl1), 292-297.
345. A. Raucci, E. Laplantine, A. Mansukhani and C. Basilico (2004) Activation of the ERK1/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes. J Biol Chem. 279(3), 1747-1756.
346. V. Raz, Z. Kelman, A. Avivi, G. Neufeld, D. Givol and Y. Yarden (1991) PCR-based identification of new receptors: Molecular cloning of a receptor for fibroblast growth factors. Oncogene 6 753-760.
347. W. Reardon, R.M. Winter, P. Rutland, L.J. Pulleyn, B.M. Jones and S. Malcolm (1994) Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genet. 8 98-103.
348. H.H. Reid, A.F. Wilks and O. Bernard (1990) Two forms of the basic fibroblast growth factor receptor-like mRNA are expressed in the developing mouse brain. Proc. Natl. Acad. Sci. USA 87 1596-1600.
349. J. Reiland and A.C. Rapraeger (1993) Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations. J. Cell. Sci. 105 1085-1093.
350. M.I. Reinhold and M.C. Naski (2007) Direct interactions of Runx2 and canonical Wnt signaling induce FGF18. J. Biol. Chem. 282(6), 3653-3663.
351. M.I. Reinhold, M. Abe, R.M. Kapadia, Z. Liao and M.C. Naski (2004) FGF18 represses noggin expression and is induced by calcineurin. J. Biol. Chem. 279 38209-38219.
352. D.P. Rice, T. Aberg, Y. Chan, Z. Tang, P.J. Kettunen, L. Pakarinen, R.E. Maxson and I. Thesleff (2000) Integration of FGF and TWIST in calvarial bone and suture development. Development 127 1845-1855.
353. L. Rifas, M.J. McDermott, S.F. Zhang, C. Olivier, L.V. Avioli and S.L. Cheng (1995) Basic fibroblast growth factor inhibits growth and differentiation of human bone marrow osteoprogenitor cells. J. Bone Miner. Res. 10(1), S411.
354. D.B. Rifkin and D. Moscatelli (1989) Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109 1-6.
355. S.C. Robertson, A.N. Meyer, K.C. Hart, B.D. Galvin, M.K. Webster and D.J. Gonoghue (1998) Activating mutations in the extracellular domain of the fibroblast growth factor 2 function by disryption of the disulfide bond in the third immunoglobulin-like domain. Proc. Natl. Acad. Sci. USA 95 4567-4572.
356. S.B. Rodan, G. Wesolowski, K. Thomas and G.A. Rodan (1987) Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor. Endocrinology 121 1917-1923.
357. S.B. Rodan, G. Wesolowski, K. Yoon and G.A. Rodan (1989) Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin, and type I collagen mRNA levels in ROS 1.7/2.8 cells. J. Biol. Chem. 264 19934-19941.
358. S. Rogelj, R.A. Weinberg, P. Fanning and M. Klagsbrun (1988) Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature 331 173-175.
359. S. Rogelj, M. Klagsbrun, R. Atzmon, M. Kurokawa, A. Haimovitz, Z. Fuks and I. Vlodavsky (1989) Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells. J. Cell Biol. 109 823-831.
360. M. Roghani, A. Mansukhani, P. Dell'Era, P. Bellosta, C. Basilico, D.B. Rifkin and D. Moscatelli (1994) Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J. Biol. Chem. 269 3976-3984.
361. F. Rousseau, J. Bonaventure, L. Legeal-Mallet, A. Pelet, J.-M. Rozet, P. Maroteaux, M. Le Merrer and A. Munnich (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371 252-254.
362. F. Rousseau, P. Saugier, M. Le Merrer, A. Munnich, A.L. Delezoide, P. Maroteaux, J. Bonaventure, F. Narcy and M. Sanak (1995) Stop codon FGFR3 mutations in thanatophoric dwarfism type 1. Nature Genet. 10 11-12.
363. O. Rozenblatt-Rosen, E. Mosonego-Ornan, E. Sadot, L. Madar-Shapiro, Y. Sheinin, D. Ginsberg and A. Yayon (2002) Induction of chondrocyte growth arrest by FGF: Transcriptional and cytoskeletal alterations. J. Cell. Sci. 115 553-562.
364. E. Ruoslahti and Y. Yamaguchi (1991) Proteoglycans as modulators of growth factor activities. Cell 64 867-869.
365. M. Ruta, R. Howk, G. Ricca, W. Drohan, M. Zabelshansky, G. Laureys, D.E. Barton, U. Francke, J. Schlessinger and D. Givol (1988) A novel protein tyrosine kinase gene whose expression is modulated during endothelial cell differentiation. Oncogene 3 9-15.
366. P.B. Saadeh, B.J. Mehrara, D.S. Steinbrech, J.A. Spector, J.A. Greenwald, G.S. Chin, H. Ueno, G.K. Gittes and M.T. Longaker (2000) Mechanisms of fibroblast growth factor-2 modulation of vascular endothelial growth factor expression by osteoblastic cells. Endocrinology 141 2075-2083.
367. M.G. Sabbieti, L. Marchetti, C. Abreu, A. Montero, A.R. Hand, L.G. Raisz and M.M. Hurley (1999) Prostaglandins regulate the expression of fibroblast growth factor-2 in bone. Endocrinology 140 434-444.
368. M. Sahni, D.C. Ambrosetti, A. Mansukhani, R. Gertner, D. Levy and C. Basilico (1999) FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev. 13 1361-1366.
369. O. Saksela and D.B. Rifkin (1990) Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell Biol. 110 767-775.
370. O. Saksela, D. Moscatelli, A. Sommer and D.B. Rifkin (1988) Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 107 743-751.
371. R. Sasada, T. Kurokawa, M. Iwane and K. Igarashi (1988) Transformation of mouse balb/c 3T3 cells with human basic fibroblast growth factor cDNA. Mol. Cell Biol. 8 588-594.
372. L.J. Schedlich, J.L. Flanagan, L.A. Crofts, S.A. Gillies, D. Goldberg, N.A. Morrison and J.A. Eisman (1994) Transcriptional activation of the human osteocalcin gene by basic fibroblast growth factor. J. Bone Miner. Res 9 143-152.
373. J. Schlessinger, I. Lax and M. Lemmon (1995) Regulation of growth factor activation by proteoglycans: What is the role of the low affinity receptors? Cell 83 357-360.
374. J. Schlessinger, A.N. Plotnikov, O.A. Ibrahimi, A.V. Eliseenkova, B.K. Yeh and A. Yayon (2000) Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 6 743-750.
375. A. Scutt and P. Bertram (1999) Basic fibroblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiaion by rat bone marrow stromal cells. Calcif. Tissue Int. 64 69-77.
376. O. Segev, I. Chumakov, Z. Nevo, D. Givol, L. Madar-Shapiro, Y. Sheinin, M. Weinreb and A. Yayon (2000) Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice. Hum. Mol. Genet. 9 249-258.
377. K. Sekine, H. Ohuchi, M. Fujiwara, M. Yamasaki, T. Yoshizawa, T. Sato, N. Yagishita, D. Matsui, Y. Koga, N. Itoh and S. Kato (1999) Fgf10 is essential for limb and lung formation. Nature Genet. 21(1), 138-141.
378. S.M. Seyedin, T.C. Thomas, A.Y. Thompson, D.M. Rosen and K.A. Diez (1985) Purification and characterization of two cartilage inducing factors from bovine demineralized bone. Proc. Natl. Acad. Sci. USA 82 2267-2271.
379. V. Shen, G. Kohler, J. Huang, S.S. Huang and W.A. Peck (1989) An acidic fibroblast growth factor stimulates DNA synthesis, inhibits collagen and alkaline phosphatase synthesis and induces resorption in bone. Bone Miner. 7 205-219.
380. J. Shi, S. Friedman and T. Maciag (1997) The carboxy-terminal half of FGF-1 is involved in the regulation of FGF-1 secretion in response to heat shock. J. Biol. Chem. 272 1142-1147.
381. R. Shiang, L.M. Thompson, Y.-Z. Zhu, D.M. Church, T.J. Fielder, M. Bocian, S.T. Winokur and J.J. Wasmuth (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78 335-342.
382. H. Shiba, S. Nakamura, M. Shirakawa, K. Nakanishi, H. Okamoto, H. Satakeda, M. Noshiro, K. Kamihagi, M. Katayama and Y. Kato (1995) Effects of basic fibroblast growth factor on proliferation, the expression of osteonectin (SPARC) and alkaline phosphatase, and calcification in cultures of human pulp cells. Dev. Biol. 170 457-466.
383. F. Shibata, A. Baird and R.Z. Florkiewicz (1991) Functional characterization of the human basic fibroblast growth factor gene promoter. Growth Factors 4 277-287.
384. A. Shimazu, H.D. Nah, T. Kirsch, E. Koyama, J.L. Leatherman, E.B. Golden, R.A. Kosher and M. Pacifici (1996) Syndecan-3 and the control of chondrocyte proliferation during endochondral ossification. Exp. Cell Res. 229 126-136.
385. T. Shimoaka, T. Ogasawara, A. Yonamine, D. Chikazu, H. Kawano, K. Nakamura, N. Itoh and H. Kawaguchi (2002) Regulation of osteoblast, chondrocyte, and osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF-10. J. Biol. Chem. 277 7493-7500.
386. Y. Shing, J. Folkman, R. Sullivan, C. Butterfield, J. Murray and M. Klagsbrun (1984) Heparin affinity: Purification of a tumor-derived capillary endothelial cell growth factor. Science 223 1296-1299.
387. M. Shiokawa-Sawada, H. Mano, K. Hanada, S. Kakudo, T. Kameda, K. Miyazawa, Y. Nakamaru, T. Yuasa, Y. Mori, M. Kumegawa and Y. Hakeda (1997) Down-regulation of gap junctional intercellular communication between osteoblastic MC3T3-E1 cells by basic fibroblast growth factor and a phorbol ester (12-0-tetradecanoylphorbol-13-acetate). J. Bone Miner. Res. 12 1165-1173.
388. H.A. Simmons, K.A. Thomas and L.G. Raisz (1991) Effects of acidic and basic fibroblast growth factor and heparin on resorption of cultured fetal rat long bone. J. Bone Miner. Res 6 1301-1305.
389. P.M. Smallwood, I. Munoz-Sanjuan, P. Tong, J.P. Macke, S.H.C. Hendry, D.C. Gilbert, N.G. Copeland, N.A. Jenkins and J. Nathens (1996) Fibroblast growth factor (FGF) homologous factors: New members of the FGF family implicated in nervous system development. Proc. Natl. Acad. Sci. USA 93 9850-9857.
390. T. Sobue, T. Naganawa, L. Xiao, Y. Okada, Y. Tanaka, M. Ito, N. Okimoto, T. Nakamura, J.D. Coffin and M.M. Hurley (2005) Overexpressing fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice. J. Cell. Biochem. 95 83-94.
391. L.A. Solchaga, K. Penick, J.D. Porter, V.M. Goldberg, A.I. Caplan and J.F. Welter (2005) FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J. Cell. Physiol. 203(2), 398-409.
392. M. Solursh, R.S. Reiter, K.L. Jensen, M. Kato and M. Bernfield (1990) Transient expression of a cell surface heparan sulfate proteoglycan (syndecan) during limb development. Dev. Biol. 140 83-92.
393. S.J. Song, S.M. Cool and V. Nurcombe (2007) Regulated expression of syndecan-4 in rat calvaria osteoblasts induced by fibroblast growth factor-2. J. Cell Biochem. 100(2), 402-411.
394. N. Sorgente, K.E. Kuettner, L.W. Soble and R. Eisenstein (1975) The resistance of certain tissues to invasion. Lab. Invest. 32 217-222.
395. A. Sorokin, M. Mohammadi, J. Huang and J. Schlessinger (1994) Internalization of fibroblast growth factor receptor is inhibited by a point mutation at tyrosine 766. J. Biol. Chem. 269(25), 17056-17061.
396. M. Steegmaier, A. Levinovitz, S. Isenmann, E. Borges, M. ‘Lenter, H.P. Kocher, B. Kleuser and D. Vestweber (1995) The E-selectin ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature 373 615-620.
397. A. Stieber, Z. Mourelatos, Y.J. Chen, N. Le Douarin and N.K. Gonatas (1995) MG160, a membrane protein of the Golgi apparatus which is homologous to a fibroblast growth factor receptor and to a ligand for E-selectin, is found only in the Golgi apparatus and appears early in chicken embryo development. Exp. Cell Res. 219 562-570.
398. N.S. Stott, T.X. Jiang and C.M. Chuong (1999) Successive formative stages of precartilaginous mesenchymal condensations in vitro: Modulation of cell adhesion by Wnt-7A and BMP-2. J. Cell Physiol. 180 314-324.
399. W.C. Su, M. Kitagawa, N. Xue, B. Xie, S. Garofalo, J. Cho, C. Deng, W.A. Horton and X.Y. Fu (1997) Activation of Statl by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386 288-292.
400. T. Suda, N. Takahashi and T.J. Martin (1992) Modulation of osteoclast differentiation. Endocr. Rev. 13 66-80.
401. A. Superti-Furga, G. Eich, H.U. Bucher, J. Wisser, A. Giedion, R. Gitzelmann and B. Steinmann (1995) A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia. Eur. J. Pediatr. 54 215-219.
402. G. Szebenyi and J.F. Fallon (1999) Fibroblast growth factors as multifunctional signaling factors. Int. Rev. Cytol. 185 45-106.
403. G. Szebenyi, M.P. Savage, B.B. Olwin and J.F. Fallon (1995) Changes in the expression of fibroblast growth factor receptors mark distinct stages of chondrogenesis in vitro and during chick limb skeletal patterning. Dev. Dyn. 204 446-456.
404. Y. Tabata, K. Yamada, L. Hong, S. Miyamoto, N. Hashimoto and Y. Ikada (1999) Skull bone regeneration in primates in response to basic fibroblast growth factor. J. Neurosurg. 91 851-856.
405. M. Taira, T. Yoshida, K. Miyagawa, H. Sakamoto, M. Terada and T. Sugimura (1987) cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. Proc. Natl. Acad. Sci. USA 84 2980-2984.
406. S. Takai, H. Tokuda, Y. Hanai, A. Harada, E. Yasuda, R. Matsushima-Nishiwaki, H. Kato, S. Ogura, T. Ohta and O. Kozawa (2007) Negative regulation by p70 S6 kinase of FGF-2-stimulated VEGF release through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts. J. Bone Miner. Res. 22(3), 337-346.
407. H. Tanaka, H. Ogasa, J. Barnes and C.T. Liang (1999) Actions of bFGF on mitogenic activity and lineage expression in rat osteoprogenitor cells: Effect of age. Mol. Cell Endocrinol. 25 1-10.
408. K.T. Tang, C. Capparelli, J.L. Stein, G.S. Stein, J.B. Lian, A.C. Huber, L.E. Braverman and W.J. DeVito (1996) Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro: Altered expression of collagenase, cell growth-related, and mineralization-associated genes. J. Cell. Biochem. 61 152-166.
409. C.H. Tang, R.S. Yang, Y.F. Chen and W.M. Fu (2007) Basic fibroblast growth factor stimulates fibronectin expression through phospholipase C gamma, protein kinase C alpha, c-Src, NF-κB, and p300 pathway in osteoblasts. J. Cell. Physiol. 211(1), 45-55.
410. Y. Tanimoto, M. Yokozeki, K. Hiura, K. Matsumoto, H. Nakanishi, T. Matsumoto, P.J. Marie and K. Moriyama (2004) A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome. J. Biol. Chem. 279(44), 45926-45934.
411. P.L. Tavormina, R. Shiang, L.M. Thompson, Y.Z. Zhu, D.J. Wilkin, R.S. Lachman, W.R. Wilcox, D.L. Rimoin, D.H. Cohn and J.J. Wasmuth (1995) Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat. Genet. 9 321-328.
412. K.A. Thomas, M.C. Riley, S.K. Lemmon, N.C. Baglan and R.A. Bradshaw (1980) Brain fibroblast growth factor: Nonidentity with myelin basic protein fragments. J. Biol. Chem. 255 5517-5520.
413. R.C. Thompson Jr (1973) Heparin osteoporosis an experimental model using rats. J. Bone Joint Surg. 55 606-612.
414. R.W. Thompson, G.F. Whalen, K.B. Saunders, T. Hores and P.A. D'Amore (1990) Heparin-mediated release of fibroblast growth factor like activity into the circulation of rabbits. Growth Factors 3 221-229.
415. C. Touriol, M. Roussigue, M.C. Gensac, H. Prats and A.C. Prats (2000) Alternative translation initiation of human fibroblast growth factor 2 mRNA controlled by its 3′-untranslated region involves a poly (A) switch and a translational enhancer. J. Biol. Chem. 275 19361-19367.
416. S.B. Trippel, J. Wroblewski, A.-M. Makower, M.C. Whelan, D. Schoenfeld and S.R. Doctrow (1993) Regulation of growth-plate chon-drocytes by insulin-like growth-factor I and basic fibroblast growth factor. J. Bone Joint Surg. 75A 177-189.
417. T. Ueba, T. Nosaka, J.A. Takahashi, F. Shibata, R.Z. Florkiewicz, B. Vogelstein, Y. Oda, H. Kikuchi and M. Hatanaka (1994) Tran-scriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells. Proc. Natl. Acad. Sci. USA 91 9009-9013.
418. T. Ueba, B. Kaspar, X. Zhao and F.H. Gage (1999) Repression of human fibroblast growth factor 2 by a novel transcription factor. J. Biol. Chem. 274(15), 10382-10387.
419. S. Vainio, M. Jalkanen, A. Vaahtokari, C. Sahlberg, M. Mali, M. Bernfield and I. Thesleff (1991) Expression of syndecan gene is induced early, is transient, and correlates with changes in mesenchymal cell proliferation during tooth organogenesis. Dev. Biol. 147 322-333.
420. S. Vagner, M.C. Gensac, A. Maret, F. Bayard, F. Amalric, H. Prats and A.C. Prats (1995) Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol. Cell Biol. 15 35-44.
421. Z. Vajo, C.A. Francomano and D.J. Wilkin (2000) The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: The achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr. Rev. 21 23-39.
422. M.P. Valta, T. Hentunen, Q. Qu, E.M. Valve, A. Harjula, J.A. Seppanen, H.K. Vaananen and P.L. Harkonen (2006) Regulation of osteoblast differentiation: A novel function for fibroblast growth factor 8. Endocrinology 147(5), 2171-2182.
423. G. Valverde-Franco, H. Liu, D. Davidson, S. Chai, H. Valderrama-Carvajal, D. Goltzman, D.M. Ornitz and J.E. Henderson (2004) Defective bone mineralization and osteopenia in young adult FGFR3−/− mice. Hum. Mol. Genet. 13(3), 271-284.
424. S. Varghese, M.L. Ramsby, J.J. Jeffrey and E. Canalis (1995) Basic fibroblast growth factor stimulates expression of interstitial collagenase and inhibitors of metalloproteinases in rat bone cells. Endocrinology 136(5), 2156-2162.
425. S. Varghese, S. Rydziel and E. Canalis (2000) Basic fibroblast growth factor stimulates collagenase-3 promoter activity in osteoblasts through an activator protein-1-binding site. Endocrinology 6 2185-2191.
426. G. Venkataraman, R. Raman, V. Sasisekharan and R. Sasisekharan (1999) Molecular characterization of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex. Proc. Nat. Acad. Sci. USA 96 3658-3663.
427. I. Vilgrain and A. Baird (1991) Phosphorylation of basic fibroblast growth factor by a protein kinase associated with the outer surface of a target cell. Mol. Endocrinol. 5 1003-1012.
428. S. Walsh, C. Jefferiss, K. Stewart, G.R. Jordan, J. Screen and J.N. Beresford (2000) Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: Regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1–4. Bone 27 185-195.
429. A. Wanaka, E.M. Milbrandt and M. Johnson (1991) Expression of FGF receptor gene in rat development. Development 111 455-468.
430. J.S. Wang (1996) Basic fibroblast growth factor for stimulation of bone formation in osteoinductive or conductive implants. Acta. Orthop. Scand. 269 1-33.
431. J.K. Wang, G. Gao and M. Goldfarb (1994) Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol. Cell. Biol. 14 181-188.
432. Y. Wang, M.K. Spatz, K. Kannan, H. Hayk, A. Avivi, M. Gorivodsky, M. Pines, A. Yayon, P. Lonai and D. Givol (1999) A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. Proc. Natl. Acad. Sci. USA 96(8), 4455-4460.
433. Q. Wang, R.P. Green, G. Zhao and D.M. Ornitz (2001) Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains. Development 2128(19), 3867-3876.
434. Y. Wang, R. Xiao, F. Yang, B.O. Karim, A.J. Iacovelli, J. Cai, C.P. Lerner, J.T. Richtsmeier, J.M. Leszl, C.A. Hill, K. Yu, D.M. Ornitz, J. Elisseeff, D.L. Huso and E.W. Jabs (2005) Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse. Development 132(15), 3537-3548.
435. S.M. Warren, L.J. Brunet, R.M. Harland, A.N. Economides and M.T. Longaker (2003) The BMP antagonist noggin regulates cranial suture fusion. Nature 422(6932), 625-629.
436. M.K. Webster, P.Y. D'Avis, S.C. Robertson and D.J. Donoghue (1996) Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol. Cell. Biol. 16 4081-4087.
437. M.K. Webster and D.J. Donoghue (1996) Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15 520-527.
438. M.K. Webster and D.J. Donoghue (1997) FGFR activation in skeletal disorders: Too much of a good thing. Trends Genet. 13(5), 178-182.
439. C. Wiesmann and A.M. de Vos (1999) Putting two and two together: Crystal structure of the FGF-receptor complex. Structure Fold Des. 7 R251-rR255.
440. R. Wildburger, N. Zarkovic, G. Egger, W. Petek, K. Zarkovic and H.P. Hofer (1994) Basic fibroblast growth factor (bFGF) immunoreactivity as a possible link between head injury and impaired bone fracture healing. Bone Miner. 27 183-193.
441. T.A. Wilke, S. Gubbels, J. Schwartz and J.M. Richman (1997) Expression of fibroblast growth factor receptors (FGFR-1, FGFR-2, FGFR-3) in the developing head and face. Dev. Dyn. 210 41-52.
442. A.O. Wilkie (2005) Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor. Rev. 16(2), 187-203.
443. A. Wong, B. Lamothe, A. Lee, J. Schlessinger and I. Lax (2002) FRS2 alpha attenuates FGF receptor signaling by Grb2-mediated recruitment of the ubiquitin ligase Cbl. Proc. Natl. Acad. Sci. USA 99(10), 6684-6689. Erratum in: Proc. Natl. Acad. Sci. USA 299(16), 10941
444. J. Wroblewski and C. Edwall-Arvidsson (1995) Inhibitory effects of basic fibroblast growth factor on chondrocyte differentiation. J. Bone Miner. Res. 10 735-742.
445. D. Wu, M. Kan, G.H. Sato, T. Okamoto and J.D. Sato (1991) Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J. Biol. Chem. 266 16778-16785.
446. G. Xiao, R. Gopalakrishnan, D. Jiang, E. Reith, M.D. Benson and R.T. Franceschi (2002) Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J. Bone Miner. Res. 17(1), 101-110.
447. L. Xiao, T. Naganawa, E. Obugunde, G. Gronowicz, D.M. Ornitz, J.D. Coffin and M.M. Hurley (2004) Stat1 controls post natal bone formation by regulating FGF signaling in osteoblasts. J. Biol. Chem. 279 27743-27751.
448. M.H. Xie, I. Holcomb, B. Deuel, P. Dowd, A. Huang, A. Vagts, J. Foster, J. Liang, J. Brush, Q. Gu, K. Hillan, A. Goddard and A.L. Gurney (1999) FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine 11 729-735.
449. J. Xu, A. Lawshe, C.A. MacArthur and D.M. Ornitz (1999) Genomic structure, mapping, activity and expression of fibroblast growth factor 17. Mech. Dev. 83 165-178.
450. X. Xu, M. Weinstein, C. Li, M. Naski, R.I. Cohen, D.M. Ornitz, P. Leder and C. Deng (1998) Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb development. Development 125 753-765.
451. X. Xu, M. Weinstein, C. Li and C. Deng (1999) Fibroblast growth factor receptors (FGFRs) and their roles in limb development. Cell Tissue Res. 296 33-43.
452. T.P. Yamaguchi, M. Harpal, M. Henkemeyer and J. Rossant (1994) FGFR-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes. Dev. 8 3032-3044.
453. T.P. Yamaguchi and J. Rossant (1995) Fibroblast growth factors in mammalian development. Curr. Opin. Genet. Dev. 5 485-491.
454. G. Yan, G. McBride and W.L. McKeehan (1993) Exon skipping causes alteration of the COOH-terminus and deletion of the phospholipase C gammal interaction site in the FGF receptor 2 kinase in normal prostate epithelial cells. Biochem. Biophys. Res. Commun. 194 512-518.
455. A. Yasoda, Y. Komatsu, H. Chusho, T. Miyazawa, A. Ozasa, M. Miura, T. Kurihara, T. Rogi, S. Tanaka, M. Suda, N. Tamura, Y. Ogawa and K. Nakao (2004) Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat. Med. 10(1), 80-86.
456. B.S. Yoon, R. Pogue, D.A. Ovchinnikov, I. Yoshii, Y. Mishina, R.R. Behringer and K.M. Lyons (2006) BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways. Development 133(23), 4667-4678.
457. Y. Yoshiko, H. Wang, T. Minamizaki, C. Ijiun, R. Yamamoto, S. Suemune, K. Kozai, K. Tanne, J.E. Aubin and N. Maeda (2007) Mineralized tissue cells are a principal source of FGF23. Bone 40 1565-1573.
458. K. Yu, A.B. Herr, G. Waksman and D.M. Ornitz (2000) Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc. Natl. Acad. Sci. USA. 97(26), 14536-14541.
459. K. Yu, J. Xu, Z. Liu, D. Sosic, J. Shao, E.N. Olson, D.A. Towler and D.M. Ornitz (2003) Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130(13), 3063-3074.
460. G. Zellin and A. Linde (2000) Effects of recombinant human fibroblast growth factor-2 on osteogenic cell populations during orthopic osteogenesis in vivo. Bone 26 61-68.
461. X. Zhan, B. Bates, X. Hu and M. Goldfarb (1988) The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors. Mol. Cell Biol. 8 3487-3497.
462. X. Zhang, T. Sobue and M.M. Hurley (2002) FGF-2 increases colony formation, PTH receptor and IGF-1 mRNA in mouse marrow stromal cells. Biochem. Biophys. Res. Commun. 290 526-531.
463. J. Zhou and P.W. Finch (1999) Identification of a novel transcriptional regulatory element within the promoter region of the keratinocyte growth factor gene that mediates inducibility to cyclic AMP. Biochim. Biophys. Acta 1446(1–2), 71-81.
464. Z. Zhou, M.E. Zuber, L.W. Burrus and B.B. Olwin (1997) Identification and characterization of a fibroblast growth factor (FGF) binding domain in the cysteine-rich FGF receptor. J. Biol. Chem. 272(8), 5167-5174.
465. M. Zhou, R.L. Sutliff, R.J. Paul, J.N. Lorenz, J.B. Hoying, C.C. Haudenschild, M. Yin, J.D. Coffin, L. Kong, E.G. Kranias, W. Luo, G.P. Boivin, J.J. Duffy, S.A. Pawlowski and T. Doetschman (1998) Fibroblast growth factor 2 control of vascular tone. Nat. Med. 4 207-210.
466. Y.X. Zhou, X. Xu, L. Chen, C. Li, S.G. Brodie and C.X. Deng (2000) A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfal and premature fusion of calvarial sutures. Hum. Mol. Genet. 12 2001-2008.